DCVC
Venture CapitalDeep tech venture capital firm focused on data-driven companies in enterprise, life sciences, and computational infrastructure.
Profile
Capital
Portfolio
7 companiesCloud-based payroll, benefits, and HR platform for small and medium businesses, serving over 400,000 companies. Originally launched as ZenPayroll in 2012 before rebranding to Gusto in 2015.
Illumio is a cybersecurity company that provides zero trust segmentation solutions to prevent breaches from spreading across data centers, cloud environments, and endpoints. The platform uses real-time visibility and automated policy enforcement to contain attacks, serving more than 20% of the Fortune 100.
Radiant Industries develops portable nuclear microreactors designed to replace diesel generators with clean, zero-emissions power. The company's flagship product, Kaleidos, is a 1 MW reactor that fits inside a shipping container. Founded by former SpaceX engineers, Radiant plans to mass-produce microreactors from its factory in Oak Ridge, Tennessee.
Amplitude is a product analytics platform that helps companies understand user behavior to build better digital products. Originally incubated at Y Combinator (W12) as a voice-to-text app called Sonalight, the founders pivoted to analytics after realizing the internal tools they built were more valuable than the app itself. The company pioneered the product intelligence category and went public via direct listing on NASDAQ in September 2021.
Alation is the pioneer of the data catalog category, providing an agentic data intelligence platform that helps enterprises discover, govern, and trust their data assets. The platform uses AI-powered search, automated documentation, and lineage tracking. Over 40% of the Fortune 100 are customers, and the company surpassed $100M in annual recurring revenue in 2022.
Clinical-stage precision oncology company that built a proprietary Predictive Precision Medicines Platform (PPMP) to bio-simulate cancer treatments and predict patient response. Originally tested combinations of FDA-approved drugs on patient cancer cell samples for blood cancers. Demonstrated 84% accuracy in predicting treatment responses with Stanford.
Developer productivity analytics platform that connected to code repositories (GitHub, Bitbucket, GitLab) and transformed commit data into reports and visualizations for engineering leaders. The platform analyzed codebases, ticketing systems, and pull requests to provide visibility into team velocity and bottlenecks.
Investment data is compiled from multiple independent sources including company announcements, press coverage, and regulatory filings. While we strive for accuracy, amounts and dates may reflect reported figures at time of announcement.